MEDIROM Healthcare Technologies Debt to Equity Ratio 2021-2024 | MRM
Current and historical debt to equity ratio values for MEDIROM Healthcare Technologies (MRM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. MEDIROM Healthcare Technologies debt/equity for the three months ending June 30, 2024 was 0.00.
| MEDIROM Healthcare Technologies Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-06-30 | $0.86B | $-0.05B | -17.00 |
| 2023-12-31 | $0.05B | $0.00B | 30.72 |
| 2023-06-30 | $0.05B | $-0.00B | -15.62 |
| 2022-12-31 | $0.05B | $0.00B | -114.69 |
| 2022-06-30 | $0.05B | $-0.00B | -15.08 |
| 2021-12-31 | $0.05B | $-0.00B | -28.61 |
| 2021-06-30 | $0.05B | $0.00B | 24.24 |
| 2020-12-31 | $0.05B | $0.01B | 10.63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.005B | $0.049B |
| MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $19.704B | 11.92 |
| Quest Diagnostics (DGX) | United States | $16.912B | 17.14 |
| DaVita (DVA) | United States | $12.098B | 15.65 |
| Encompass Health (EHC) | United States | $9.453B | 22.29 |
| Chemed (CHE) | United States | $7.853B | 24.14 |
| Elanco Animal Health (ELAN) | United States | $5.843B | 13.91 |
| RadNet (RDNT) | United States | $5.284B | 117.02 |
| Option Care Health (OPCH) | United States | $3.848B | 18.23 |
| Amedisys (AMED) | United States | $2.744B | 19.53 |
| LifeStance Health (LFST) | United States | $2.698B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.350B | 27.57 |
| Astrana Health (ASTH) | United States | $1.974B | 26.99 |
| U.S Physical Therapy (USPH) | United States | $1.380B | 36.27 |
| Pennant (PNTG) | United States | $0.938B | 37.92 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.873B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.200B | 0.00 |
| Bioqual (BIOQ) | United States | $0.059B | 0.00 |
| Daxor (DXR) | United States | $0.039B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |